RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.55

EPS Forecast

$142.7

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-06-30
NKTRNektar TherapeuticsSAGESage Therapeutics IncALKSAlkermes PlcALNYAlnylam Pharmaceuticals IncIONSIonis Pharmaceuticals IncBMRNBiomarin Pharmaceutical IncJAZZJazz Pharmaceuticals PlcSRPTSarepta Therapeutics IncPAHCPhibro Animal Health Corp